Annette North

Insider Reports History

Location
San Diego, CA
Signature
/s/ Paolo Tombesi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Annette North:

Company Role Class Num Shares Value Price $ Report Date Ownership
Turning Point Therapeutics, Inc. EVP & General Counsel Common Stock 27,979 $2,126,404 $76.00 09 Feb 2022 Direct
Turning Point Therapeutics, Inc. EVP & General Counsel Stock Option (right to buy) 58,600 09 Feb 2022 Direct

Insider Reports Filed by Annette North

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122008981-north-annette-2022-02-09 Turning Point Therapeutics, Inc. 09 Feb 2022 3 -$24,285 4 EVP & General Counsel 11 Feb 2022, 17:09
/report/000120919121054117-north-annette-2021-08-30 Turning Point Therapeutics, Inc. 30 Aug 2021 3 -$630,000 4 EVP, General Counsel & Secty. 31 Aug 2021, 17:26
/report/000120919121040984-north-annette-2021-06-15 Turning Point Therapeutics, Inc. 15 Jun 2021 5 -$900,433 4 EVP, General Counsel & Secty. 16 Jun 2021, 17:16
/report/000120919121030925-north-annette-2021-05-06 Turning Point Therapeutics, Inc. 06 May 2021 2 +$99,994 4 EVP, General Counsel & Secty. 07 May 2021, 16:37